Syensqo Q2 Net Sales Down 7 Percent EBITDA Margin Rises to 21 Percent US Listing and Business Divestiture Announced

On July 31, Syensqo released its Q2 and first-half 2025 results, reporting H1 net sales of €3.205 billion, a 3.8% decrease year over year, and gross profit of €1.02 billion, down 12.5%. For the second quarter, net sales reached €1.59 billion, falling 7.1% mainly due to negative currency effects and lower volumes, while pricing remained steady. Consumer and industrial specialty chemicals outperformed, helping offset other declines.

Q2 EBITDA came in at €335 million, with an organic year-over-year decrease of 8%, primarily due to weaker specialty polymers. However, EBITDA improved 8% sequentially. The EBITDA margin contracted 110 basis points year-over-year to 21.1%, but rebounded by 190 basis points from the previous quarter thanks to improvements in materials and solutions segments.

Net profit attributable to Syensqo shareholders was €140 million, with operating cash flow at €20 million and free cash flow at negative €67 million. The company reaffirmed its 2025 outlook, maintaining its EBITDA forecast at around €1.3 billion, factoring in about €100 million in adverse impacts from currencies and current tariffs.

Syensqo announced plans to divest non-core businesses and pursue a US listing, aiming to sharpen its specialty chemical focus. After successfully splitting IT and shared services, the company will accelerate cost-cutting initiatives in the second half, targeting annual savings over €200 million by 2026.

Despite ongoing macroeconomic headwinds, tariffs, and geopolitical uncertainty, management expects limited EBITDA downside for the year. Capital expenditure is guided to stay below €600 million, with full-year free cash flow projected at €350 million. One-off costs related to the Solvay spin-off and the Tavaux plant expansion will not recur in 2026, supporting future profitability.